ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2020年01月21日 11時00分
Source:
Azelis
Azelis presents new regional video for Asia Pacific, reinforcing its whole-hearted commitment to innovation through formulation
シンガポール, 2020年01月21日 - (JCN Newswire) - After globally launching the new Azelis tagline 'Innovation through formulation' and corporate video in July 2019, Azelis Asia Pacific now unveils its own video, which describes the forces behind the strong growth Azelis has experienced in the region over recent years. The newly released video is also a reinforcement of the company's continuous investment in formulation and application expertise.
Highlights & rationale
- Azelis launches its regional video for Asia Pacific, elaborating on growth drivers and strengths it has to offer to the territory.
- The new video is a testimony to Azelis' strategy to be an innovation service provider to all customers and sectors.
- The video is accessible here.
https://youtu.be/BLUZBZLy9o4
Azelis creates value with and for its partners by turning ideas into market-leading solutions that drive growth. The company routinely provides its customers with innovative formulations that address the most stringent market requirements and consumer trends. This is made possible through its 25 application laboratories in Asia Pacific, along with its experienced, market-focused sales teams.
The new video for Asia Pacific builds on the global Azelis brand movie, and has been created to reflect the unique culture and structure embraced by Azelis across the region. In the video, the Azelis Asia Pacific management talks about the opening of new labs, achievements in the different market segments, the growth of the 300-strong team and work-life balance and equal opportunities for all Azelis employees.
Laurent Nataf, CEO Azelis Asia Pacific, comments: "We are proud of what the Azelis team in Asia Pacific has accomplished in the past few years - it's a true testimony of the passion and dedication our team has. We have seen significant growth and have built solid partnerships with both customers and principals. Having our region-specific video now enables us to present ourselves to current and future business partners even better and to showcase the business growth and professionalism we succeeded to establish over the past couple of years."
Contact information
Azelis
Marina Kaptein
Communications Director
E-mail:
marina.kaptein@azelis.com
About Azelis
Azelis is a leading distributor of speciality chemicals and food ingredients present in over 40 countries across the globe with around 2,000 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to about 40,000 customers, creating a turnover of EUR1.94 billion (2018).
Throughout our extensive network of over 60 application laboratories, our award-winning technical staff help customers develop formulations. We combine a global reach with a local focus to offer a reliable, integrated service to local customers and attractive business opportunities to principals. And we believe in building and nurturing solid, honest and transparent relationships with our people and partners.
Impact through ideas. Innovation through formulation.
www.azelis.com
Source: Azelis
セクター: 化学, 食品・飲料, ヘルスケア, 化粧品素材
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Lexus World Premieres Lexus LFA Concept BEV Sports Car
Dec 05, 2025 19:13 JST
TOYOTA GAZOO Racing World Premieres GR GT & GR GT3
Dec 05, 2025 18:58 JST
TOYOTA GAZOO Racing and Lexus Hold World Premiere of GR GT, GR GT3, and Lexus LFA Concept
Dec 05, 2025 18:24 JST
World's First General Design Approval (GDA) for Developed Steel and Post-Weld Heat Treatment (PWHT) Exemption based on ECA for Low-pressure Liquefied CO2 Tank made of KF460 steel
Dec 05, 2025 18:17 JST
Hitachi at CES 2026: Building a Harmonized Society Through Technology
Dec 04, 2025 19:40 JST
Fujitsu and Scaleway partner to accelerate European sustainable transformation and data sovereignty with FUJITSU-MONAKA CPU-based AI inference
Dec 04, 2025 19:08 JST
NEC Orchestrating Future Fund Invests in PopID, Inc. to Accelerate Global Expansion of Biometric Payment Solutions and Launch a Strategic Collaboration
Dec 04, 2025 18:52 JST
Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI(R) (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at CTAD 2025
Dec 04, 2025 18:36 JST
The 26th Hong Kong Forum marks successful completion
Dec 03, 2025 22:44 JST
New Data Presented at CTAD 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
Dec 03, 2025 18:19 JST
Mitsubishi Motors Launches the All-New Destinator in Vietnam
Dec 03, 2025 18:00 JST
Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15
Dec 03, 2025 11:30 JST
Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025
Dec 03, 2025 00:01 JST
NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI
Dec 02, 2025 23:43 JST
Fujitsu develops new technology to support human-robot collaboration
Dec 02, 2025 23:26 JST
Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks
Dec 02, 2025 22:55 JST
Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms
Dec 01, 2025 23:04 JST
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
Dec 01, 2025 22:43 JST
Fujitsu launches 'Fujitsu Accelerator Program for SPORTS' to create new value through Sports x Technology
Dec 01, 2025 22:14 JST
Eisai Submits New Drug Application for Subcutaneous Formulation of "LEQEMBI(R)" for the Treatment of Early Alzheimer's Disease in Japan
Nov 28, 2025 23:00 JST
More Latest Release >>